BK, S., HL, M., R, C., S, M., SH, O., GL, S., . . . T, E. (2024). Microfibrillar-associated protein 4 as a predictive biomarker of treatment response in patients with chronic inflammatory diseases initiating biologics: Secondary analyses based on the prospective BELIEVE cohort study. Rheumatology international, 44(12), 2935. https://doi.org/10.1007/s00296-024-05744-9
Chicago Style (17th ed.) CitationBK, Sofíudóttir, et al. "Microfibrillar-associated Protein 4 as a Predictive Biomarker of Treatment Response in Patients with Chronic Inflammatory Diseases Initiating Biologics: Secondary Analyses Based on the Prospective BELIEVE Cohort Study." Rheumatology International 44, no. 12 (2024): 2935. https://doi.org/10.1007/s00296-024-05744-9.
MLA (9th ed.) CitationBK, Sofíudóttir, et al. "Microfibrillar-associated Protein 4 as a Predictive Biomarker of Treatment Response in Patients with Chronic Inflammatory Diseases Initiating Biologics: Secondary Analyses Based on the Prospective BELIEVE Cohort Study." Rheumatology International, vol. 44, no. 12, 2024, p. 2935, https://doi.org/10.1007/s00296-024-05744-9.